Fundz

Dalcor Pharmaceuticals Secures $80M In Series D Financing

PRIVATESep 13, 2023

Amount Raised

$80 Million

Round Type

Series D

MontrealBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Based in Montreal, DalCor Pharmaceuticals is a biopharmaceutical company with a focus on addressing cardiovascular disease.

Quick answer

DalCor Pharmaceuticals raised $80 Million in a Series D round, dated September 13, 2023. DalCor Pharmaceuticals is based in Montreal, Quebec, Canada.

How much did DalCor Pharmaceuticals raise?
DalCor Pharmaceuticals raised $80 Million in a Series D round on September 13, 2023.
What does DalCor Pharmaceuticals do?
DalCor Pharmaceuticals: DalCor Pharmaceuticals is pioneering precision medicine for patients with cardiovascular disease.
Where is DalCor Pharmaceuticals based and how big is it?
DalCor Pharmaceuticals is based in Montreal, Quebec, Canada.
Who are the decision-makers at DalCor Pharmaceuticals?
Fundz holds 1 contact at DalCor Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as DalCor Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
  • Acasti raised $7.5M (Post-IPO Equity) on September 26, 2023.
  • Acasti raised $7.5M on September 25, 2023.
  • Oragenics raised $850K (Series C) on August 4, 2023.
  • Aligos Therapeutics raised $92M on October 25, 2023.
  • Azora Therapeutics, Inc. (DE) raised $4M (Seed) on October 19, 2023.

Who to call at DalCor Pharmaceuticals, and when

A new round usually means DalCor Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DalCor Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DalCor Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DalCor Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DalCor Pharmaceuticals

Location

Montreal, Quebec, Canada

About

DalCor Pharmaceuticals: DalCor Pharmaceuticals is pioneering precision medicine for patients with cardiovascular disease. By combining genetic and clinical insights, the company’s development program, dalcetrapib, is intended to reduce fatal and non-fatal myocardial infarction (MI) following a recent acute coronary syndrome and deliver superior cardiovascular outcome in a specific genetic subset of patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DalCor Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for DalCor Pharmaceuticals's next move

See what Strategic adds

DalCor Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.